Literature DB >> 22572701

Serum prolactin concentrations in relation to hypopituitarism and obesity in children with optic nerve hypoplasia.

Amy M Vedin1, Pamela Garcia-Filion, Cassandra Fink, Mark Borchert, Mitchell E Geffner.   

Abstract

BACKGROUND/AIMS: The majority of children with optic nerve hypoplasia (ONH) develop hypopituitarism and many also become obese. These associated conditions are a major cause of morbidity and are possibly due to hypothalamic dysfunction. Because mild hyperprolactinemia often occurs in subjects with disorders of the hypothalamus, we examined whether hyperprolactinemia was present in children with ONH during the first 3 years of life and whether it was a marker for hypopituitarism and/or obesity.
METHODS: Data were retrospectively analyzed from a registry study of children with ONH. The initial serum prolactin was obtained prior to age 36 months (n = 125) and compared with pituitary function and body mass index at age 5.
RESULTS: 72% of subjects had an elevated initial serum prolactin and 60% had hypopituitarism. An elevated initial prolactin was associated with hypopituitarism (OR 2.58; 95% CI 1.16, 5.73), specifically with growth hormone deficiency (OR 2.77; 95% CI 1.21, 6.34). 31% of subjects had a body mass index ≥ 85th percentile, but this did not correlate with initial hyperprolactinemia.
CONCLUSIONS: Early hyperprolactinemia correlates with the presence of hypopituitarism in children with ONH, but it is not a reliable prognosticator of hypopituitarism. Additionally, hyperprolactinemia does not predict future weight excess.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22572701      PMCID: PMC3578391          DOI: 10.1159/000338330

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  17 in total

1.  Cognitive and behavioural characteristics in blind children with bilateral optic nerve hypoplasia.

Authors:  Ulla Ek; Elisabeth Fernell; Lena Jacobson
Journal:  Acta Paediatr       Date:  2005-10       Impact factor: 2.299

2.  Visual impairment in Swedish children. II. Etiological factors.

Authors:  J Blohmé; K Tornqvist
Journal:  Acta Ophthalmol Scand       Date:  1997-04

3.  Reversible weight gain and prolactin levels--long-term follow-up in childhood.

Authors:  F Galluzzi; R Salti; S Stagi; F La Cauza; F Chiarelli
Journal:  J Pediatr Endocrinol Metab       Date:  2005-09       Impact factor: 1.634

4.  Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in Northwest England.

Authors:  Leena Patel; Richard J Q McNally; Elizabeth Harrison; I Christopher Lloyd; Peter E Clayton
Journal:  J Pediatr       Date:  2006-01       Impact factor: 4.406

5.  Endocrinological and auxological abnormalities in young children with optic nerve hypoplasia: a prospective study.

Authors:  Tariq Ahmad; Pamela Garcia-Filion; Mark Borchert; Francine Kaufman; Linda Burkett; Mitchell Geffner
Journal:  J Pediatr       Date:  2006-01       Impact factor: 4.406

6.  Dynamics of obesity and chronic health conditions among children and youth.

Authors:  Jeanne Van Cleave; Steven L Gortmaker; James M Perrin
Journal:  JAMA       Date:  2010-02-17       Impact factor: 56.272

Review 7.  Optic nerve hypoplasia: changing perspectives.

Authors:  C S Hoyt; F A Billson
Journal:  Aust N Z J Ophthalmol       Date:  1986-11

8.  Prevalence of high body mass index in US children and adolescents, 2007-2008.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Molly M Lamb; Katherine M Flegal
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

9.  Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels.

Authors:  Y Greenman; K Tordjman; N Stern
Journal:  Clin Endocrinol (Oxf)       Date:  1998-05       Impact factor: 3.478

10.  Neuroradiographic, endocrinologic, and ophthalmic correlates of adverse developmental outcomes in children with optic nerve hypoplasia: a prospective study.

Authors:  Pamela Garcia-Filion; Karen Epport; Marvin Nelson; Colleen Azen; Mitchell E Geffner; Cassandra Fink; Mark Borchert
Journal:  Pediatrics       Date:  2008-02-04       Impact factor: 7.124

View more
  5 in total

1.  Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

2.  Brain Malformations Do Not Predict Hypopituitarism in Young Children with Optic Nerve Hypoplasia.

Authors:  Pamela Garcia-Filion; Hashem Almarzouki; Cassandra Fink; Mitchell Geffner; Marvin Nelson; Mark Borchert
Journal:  Horm Res Paediatr       Date:  2017-08-22       Impact factor: 2.852

3.  Policaptil Gel Retard significantly reduces body mass index and hyperinsulinism and may decrease the risk of type 2 diabetes mellitus (T2DM) in obese children and adolescents with family history of obesity and T2DM.

Authors:  Stefano Stagi; Elisabetta Lapi; Salvatore Seminara; Paola Pelosi; Paolo Del Greco; Laura Capirchio; Massimo Strano; Sabrina Giglio; Francesco Chiarelli; Maurizio de Martino
Journal:  Ital J Pediatr       Date:  2015-02-15       Impact factor: 2.638

4.  Endocrine and pubertal disturbances in optic nerve hypoplasia, from infancy to adolescence.

Authors:  Oliver J Oatman; Donald R McClellan; Micah L Olson; Pamela Garcia-Filion
Journal:  Int J Pediatr Endocrinol       Date:  2015-04-15

5.  Efficacy of growth hormone replacement on anthropometric outcomes, obesity, and lipids in children with optic nerve hypoplasia and growth hormone deficiency.

Authors:  Carly Stewart; Pamela Garcia-Filion; Cassandra Fink; Anna Ryabets-Lienhard; Mitchell E Geffner; Mark Borchert
Journal:  Int J Pediatr Endocrinol       Date:  2016-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.